• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

中国药物评价 ›› 2020, Vol. 37 ›› Issue (1): 61-65.

• 国际理论与方法前沿 • 上一篇    下一篇

世界卫生组织药品检查分析

颜若曦,李小春,曹轶   

  1. 国家药品监督管理局食品药品审核查验中心
  • 收稿日期:2020-01-08 修回日期:2020-02-05 出版日期:2020-02-28 发布日期:2020-03-30

Analysis of WHO Drug Inspection

  • Received:2020-01-08 Revised:2020-02-05 Online:2020-02-28 Published:2020-03-30

摘要: 对世界卫生组织(WHO)药品检查技术指南及其药品检查基本程序进行梳理总结,对近年来WHO对我国药品生产企业检查情况及缺陷进行了统计分析,进一步明确了WHO药品检查技术指南结构框架及检查基本程序。识别出我国药品生产企业在WHO检查中存在的主要缺陷分布情况及常见问题,为我国制药行业质量管理能力的提升提供参考与借鉴,为药品生产企业顺利接受WHO检查提出改进方向与建议。

关键词: 药品检查, 预认证, 世界卫生组织, 药品生产质量管理规范

Abstract: Analyzed the WHO technical guidelines and basic procedures of drug inspection, and conducted a statistical analysis on the WHO inspection situations and observations of Chinese drug manufacturers in recent years. Based on these analyses, the WHO technical guidelines structure frameworks and basic inspection procedures of drug inspection are further clarified, and the distribution of major observations and common problems existing in WHO inspection of Chinese drug manufacturers are identified.It provides reference for improving the quality management abilities of Pharmaceutical Industry, and providesimprovement directions and suggestions for pharmaceutical manufacturers to undergo WHO inspections successfully.

Key words: Druginspection, Prequalification, World Health Organization(WHO), Good manufacture practice(GMP)

中图分类号: